Cargando…
Polypharmacy Among Privately Insured Adults with Cerebral Palsy: A Retrospective Cohort Study
BACKGROUND: Adults with cerebral palsy (CP) have increased risk for developing various secondary chronic diseases, especially when they have other neurodevelopmental disabilities (NDDs). Multiple medications are likely prescribed to manage the greater morbidity-related burden for adults with CP; how...
Autores principales: | Whitney, Daniel G., Schmidt, Mary, Peterson, Mark D., Haapala, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391110/ https://www.ncbi.nlm.nih.gov/pubmed/32857655 http://dx.doi.org/10.18553/jmcp.2020.26.9.1153 |
Ejemplares similares
-
Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy
por: Whitney, Daniel G, et al.
Publicado: (2021) -
Navigating the Pathway to Care in Adults With Cerebral Palsy
por: Hurvitz, Edward A., et al.
Publicado: (2021) -
ACCELERATED AGING AMONG ADULTS LIVING WITH CEREBRAL PALSY
por: Peterson, Mark, et al.
Publicado: (2022) -
NAVIGATING THE PATHWAY TO CARE IN ADULTS WITH CEREBRAL PALSY
por: Haapala, Heidi
Publicado: (2022) -
Opioid prescription patterns among adults with cerebral palsy and spina bifida
por: Peterson, Mark D., et al.
Publicado: (2022)